Sargent Investment Group, LLC Intra Cellular Therapies, Inc. Transaction History
Sargent Investment Group, LLC
- $483 Million
- Q2 2024
Shares
3 transactions
Others Institutions Holding ITCI
# of Institutions
400Shares Held
87.2MCall Options Held
309KPut Options Held
302K-
Vanguard Group Inc Valley Forge, PA9.61MShares$704 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.32MShares$463 Million0.01% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT3.72MShares$273 Million1.37% of portfolio
-
Jpmorgan Chase & CO New York, NY3.44MShares$252 Million0.02% of portfolio
-
Avoro Capital Advisors LLC New York, NY3MShares$220 Million2.8% of portfolio
About Intra-Cellular Therapies, Inc.
- Ticker ITCI
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 94,401,696
- Market Cap $6.92B
- Description
- Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...